NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

Why didn't her hypothetical trial end with no SOC only patients receiving treatment? That does not seem to fit a trial that has no chance of statistically significant endpoints. Everything must fit. Clinical observations vs trial parameters appear to be the difference. Trial parameters win the discussion when a trial is referrenced by a principal investigator. The trial is probably still waiting on final adjudication and Dr. Linda Liau would not comment on that. If an option is still available it's best not to write it off too soon.

Try to enjoy your time off chillaxing and if you can't stay away then focus on the big picture because it is almost done and you helped draw it for us. You have put in a ton of time here and we all appreciate it. Best wishes.